307 related articles for article (PubMed ID: 31960363)
1. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
Breast Cancer; 2020 Jul; 27(4):573-585. PubMed ID: 31960363
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y
BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
Stenström J; Hedenfalk I; Hagerling C
Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
[TBL] [Abstract][Full Text] [Related]
4. Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA.
Shen S; Chen X; Hu X; Huo J; Luo L; Zhou X
Cancer Med; 2021 Sep; 10(18):6561-6575. PubMed ID: 34378851
[TBL] [Abstract][Full Text] [Related]
5. MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers.
Peng L; Chen Z; Chen Y; Wang X; Tang N
Cancer Med; 2019 Dec; 8(17):7161-7173. PubMed ID: 31568700
[TBL] [Abstract][Full Text] [Related]
6. Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes.
Wang Z; Liu W; Chen C; Yang X; Luo Y; Zhang B
Sci Rep; 2019 Jan; 9(1):253. PubMed ID: 30670769
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
8. Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis.
de Santiago PR; Blanco A; Morales F; Marcelain K; Harismendy O; Sjöberg Herrera M; Armisén R
Life Sci; 2021 Mar; 268():118956. PubMed ID: 33383047
[TBL] [Abstract][Full Text] [Related]
9. KRAS expression is a prognostic indicator and associated with immune infiltration in breast cancer.
Liang H; Zhou G; Lv L; Lu J; Peng J
Breast Cancer; 2021 Mar; 28(2):379-386. PubMed ID: 33067762
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
[TBL] [Abstract][Full Text] [Related]
11. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
DNA Cell Biol; 2019 Dec; 38(12):1529-1539. PubMed ID: 31647329
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J
Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
14. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study.
Li YC; Zhou Q; Song QK; Wang RB; Lyu S; Guan X; Zhao YJ; Wu JP
J Immunol Res; 2020; 2020():3948928. PubMed ID: 32411795
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
17. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
18. Increased long noncoding RNA LINP1 expression and its prognostic significance in human breast cancer.
Liu XM; Yang B; Han J
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8749-8754. PubMed ID: 30575915
[TBL] [Abstract][Full Text] [Related]
19. The Role of CXCL13 and CXCL9 in Early Breast Cancer.
Razis E; Kalogeras KT; Kotsantis I; Koliou GA; Manousou K; Wirtz R; Veltrup E; Patsea H; Poulakaki N; Dionysopoulos D; Pervana S; Gogas H; Koutras A; Pentheroudakis G; Christodoulou C; Linardou H; Pavlakis K; Koletsa T; Pectasides D; Zagouri F; Fountzilas G
Clin Breast Cancer; 2020 Feb; 20(1):e36-e53. PubMed ID: 31699671
[TBL] [Abstract][Full Text] [Related]
20. CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.
Liu S; Lachapelle J; Leung S; Gao D; Foulkes WD; Nielsen TO
Breast Cancer Res; 2012 Mar; 14(2):R48. PubMed ID: 22420471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
